| Jennifer Palombo, | |
|
13123 E 16th Ave, Aurora, CO 80045-7106 | |
| (720) 777-1234 | |
| Not Available |
| Full Name | Jennifer Palombo |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 13123 E 16th Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861974958 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians Incorporated | 3476465667 | 2657 |
News Archive
Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today the resubmission of Impax's New Drug Application (NDA) for RYTARY (IPX066) to the U.S. Food and Drug Administration (FDA).
Democratic congressional leaders in January 2007 plan to approve a bill similar to a measure (HR 810) President Bush vetoed earlier this year that would have expanded federal funding for human embryonic stem cell research, the AP/Houston Chronicle reports (Kellman, AP/Houston Chronicle, 11/29).
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that the U.S. Department of Homeland Security recently issued a Federal warning about the increased risk of carbon monoxide exposure during the winter season—urging heightened awareness and precaution for firefighters, who are at increased risk of duty-related CO danger. The life-threatening consequences of CO poisoning make immediate detection, helped by the noninvasive Masimo Rad-57 Pulse CO-Oximeter, a lifesaving necessity for fire and emergency operations.
Axolotl Corp., the nationwide leader in health information exchange (HIE) services and solutions, celebrates fifteen successful years of software development and HIE implementation. Since its founding in 1995, Axolotl has been providing advanced Clinical Networking™ solutions to meet the diverse and changing needs of physicians, hospitals, regional health information organizations (RHIOs) and statewide HIEs to achieve interoperability across entire medical trading areas.
Transition Therapeutics Inc. announced today that Transition Therapeutics Ireland Limited has entered into an agreement for an investigator-led clinical study of drug candidate, TT701, with Brigham and Women's Hospital.
› Verified 9 days ago
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today the resubmission of Impax's New Drug Application (NDA) for RYTARY (IPX066) to the U.S. Food and Drug Administration (FDA).
Democratic congressional leaders in January 2007 plan to approve a bill similar to a measure (HR 810) President Bush vetoed earlier this year that would have expanded federal funding for human embryonic stem cell research, the AP/Houston Chronicle reports (Kellman, AP/Houston Chronicle, 11/29).
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that the U.S. Department of Homeland Security recently issued a Federal warning about the increased risk of carbon monoxide exposure during the winter season—urging heightened awareness and precaution for firefighters, who are at increased risk of duty-related CO danger. The life-threatening consequences of CO poisoning make immediate detection, helped by the noninvasive Masimo Rad-57 Pulse CO-Oximeter, a lifesaving necessity for fire and emergency operations.
Axolotl Corp., the nationwide leader in health information exchange (HIE) services and solutions, celebrates fifteen successful years of software development and HIE implementation. Since its founding in 1995, Axolotl has been providing advanced Clinical Networking™ solutions to meet the diverse and changing needs of physicians, hospitals, regional health information organizations (RHIOs) and statewide HIEs to achieve interoperability across entire medical trading areas.
Transition Therapeutics Inc. announced today that Transition Therapeutics Ireland Limited has entered into an agreement for an investigator-led clinical study of drug candidate, TT701, with Brigham and Women's Hospital.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Palombo, Po Box 110429, Aurora, CO 80042-0429 Ph: (303) 493-7000 | Jennifer Palombo, 13123 E 16th Ave, Aurora, CO 80045-7106 Ph: (720) 777-1234 |
News Archive
Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today the resubmission of Impax's New Drug Application (NDA) for RYTARY (IPX066) to the U.S. Food and Drug Administration (FDA).
Democratic congressional leaders in January 2007 plan to approve a bill similar to a measure (HR 810) President Bush vetoed earlier this year that would have expanded federal funding for human embryonic stem cell research, the AP/Houston Chronicle reports (Kellman, AP/Houston Chronicle, 11/29).
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that the U.S. Department of Homeland Security recently issued a Federal warning about the increased risk of carbon monoxide exposure during the winter season—urging heightened awareness and precaution for firefighters, who are at increased risk of duty-related CO danger. The life-threatening consequences of CO poisoning make immediate detection, helped by the noninvasive Masimo Rad-57 Pulse CO-Oximeter, a lifesaving necessity for fire and emergency operations.
Axolotl Corp., the nationwide leader in health information exchange (HIE) services and solutions, celebrates fifteen successful years of software development and HIE implementation. Since its founding in 1995, Axolotl has been providing advanced Clinical Networking™ solutions to meet the diverse and changing needs of physicians, hospitals, regional health information organizations (RHIOs) and statewide HIEs to achieve interoperability across entire medical trading areas.
Transition Therapeutics Inc. announced today that Transition Therapeutics Ireland Limited has entered into an agreement for an investigator-led clinical study of drug candidate, TT701, with Brigham and Women's Hospital.
› Verified 9 days ago
Laura Tierney Yost, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Mrs. Janassa Opichka, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Kathleen Manning, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Jody Slebodnik Barnes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Jamie E Seeley, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 3000 S Jamaica Ct Ste 140, Aurora, CO 80014 Phone: 866-773-4252 Fax: 866-815-7277 | |
Emma Batchelder, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1501 S Potomac St, Aurora, CO 80012 Phone: 720-848-0000 | |
Matthew T Kopp, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |